NextPlat (NXPL) Net Margin (2015 - 2026)
NextPlat's (NXPL) quarterly Net Margin came in at 1.21% in Q2 2026, up 1230.0% year-over-year from 0.09% in Q2 2025, and up 89.32% quarter-over-quarter from 11.34% in Q1 2026.
Powered by 
Analysis
NextPlat (NXPL) Net Margin (2015 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Net Margin for 12 consecutive years, with 1.21% the latest figure, recorded in Q2 2026.
- On a quarterly basis, Net Margin rose 1230.0% year-over-year to 1.21% in Q2 2026; TTM through Jun 2026 was 20.38%, a 274.0% decrease from a year earlier, with the FY2025 full-year figure at 21.56%, down 124.0% from the prior year.
- Net Margin was 1.21% for Q2 2026 at NextPlat, up from 11.34% in the prior quarter.
- Over five years, Net Margin peaked at 22.55% in Q3 2023 and troughed at 217.17% in Q3 2022.
- A 5-year average of 38.78% and a median of 19.82% in 2025 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 11471 bps in 2022 and soared 23972 bps in 2023, its largest moves.
- Over 5 years, Net Margin stood at 35.81% in 2022, then soared by 71 bps to 10.21% in 2023, then sank by 46 bps to 14.9% in 2024, then sank by 235 bps to 49.94% in 2025, then soared by 98 bps to 1.21% in 2026.
- The last three Net Margin figures came in at 1.21% (Q2 2026), 11.34% (Q1 2026), and 49.94% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -13.91% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -3.16% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 5.50% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 8.74% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 9.12% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 9.28% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -121.81% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 16.50% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 11.04% |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | -1.21% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.21% |
| Mar 31, 2026 | -11.34% |
| Dec 31, 2025 | -49.94% |
| Sep 30, 2025 | -15.89% |
| Jun 30, 2025 | -13.51% |
| Mar 31, 2025 | -13.95% |
| Dec 31, 2024 | -14.90% |
| Sep 30, 2024 | -27.44% |
| Jun 30, 2024 | -31.26% |
| Mar 31, 2024 | -8.47% |
| Dec 31, 2023 | -10.21% |
| Sep 30, 2023 | 22.55% |
| Jun 30, 2023 | -146.80% |
| Mar 31, 2023 | -41.27% |
| Dec 31, 2022 | -35.81% |
| Sep 30, 2022 | -217.17% |
| Jun 30, 2022 | -57.67% |
| Mar 31, 2022 | -23.76% |
| Dec 31, 2021 | -170.88% |
| Sep 30, 2021 | -102.46% |